Literature DB >> 20456362

Age-related complications in treatment-naïve patients with thalassaemia intermedia.

Ali T Taher, Khaled M Musallam, Amal El-Beshlawy, Mehran Karimi, Shahina Daar, Khawla Belhoul, Mohamed-Salaheldin Saned, Giovanna Graziadei, Maria D Cappellini.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20456362     DOI： 10.1111/j.1365-2141.2010.08220.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  32 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.

Authors:  Adisak Tantiworawit; Pimlak Charoenkwan; Sasinee Hantrakool; Worawut Choeyprasert; Chate Sivasomboon; Torpong Sanguansermsri
Journal:  Int J Hematol       Date:  2016-04-06       Impact factor: 2.490

Review 3.  Management of non-transfusion-dependent thalassemia: a practical guide.

Authors:  Ali T Taher; Maria Domenica Cappellini
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

4.  Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study.

Authors:  Paolo Ricchi; Massimiliano Ammirabile; Silvia Costantini; Anna Spasiano; Tiziana Di Matola; Roberto Verna; Alessia Pepe; Patrizia Cinque; Caterina Saporito; Aldo Filosa; Leonilde Pagano
Journal:  Blood Transfus       Date:  2016-05-03       Impact factor: 3.443

5.  Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.

Authors:  Rajasekhar N V S Suragani; Sharon M Cawley; Robert Li; Samantha Wallner; Mark J Alexander; Aaron W Mulivor; Sara Gardenghi; Stefano Rivella; Asya V Grinberg; R Scott Pearsall; Ravindra Kumar
Journal:  Blood       Date:  2014-05-02       Impact factor: 22.113

6.  Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.

Authors:  Khaled M Musallam; Maria Domenica Cappellini; John C Wood; Irene Motta; Giovanna Graziadei; Hani Tamim; Ali T Taher
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

Review 7.  Cardiac complications in beta-thalassemia: From mice to men.

Authors:  Sirinart Kumfu; Suthat Fucharoen; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-09

Review 8.  Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.

Authors:  Matt Shirley; Greg L Plosker
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

Review 9.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

Review 10.  β-Thalassemia.

Authors:  Raffaella Origa
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.